Diabetes is a complex condition that requires smart solutions to manage this health challenge effectively. With more than 40 years of experience and over 5,500 employees in more than 100 markets, Roche Diabetes Care is dedicated to advance care and foster sustainable structures to counter the diabetes epidemic.
As a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care has been pioneering innovation for more than 40 years – spanning from the first introduction of at-home testing, further simplified and strip-free blood glucose monitoring, to offering the first FDA approved bolus advisor.
Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery and digital solutions, we unite with our partners to facilitate integrated Personalised Diabetes Management. Doing so, we aim to support people with diabetes and those at risk to reach their therapy goals and spend more time in range.
With thought leaders around the world, including people with diabetes, caregivers, healthcare providers, and payers, we share the goal to transform provision of care. By building and collaborating in an open ecosystem, we drive insights and innovation to enable a deeper understanding of the disease, leading to personalised and effective therapy adjustments. For better outcomes and true relief.
Ref: 0312, Jun 2020